Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/1465-9921-7-26.

Title:
Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo | Respiratory Research
Description:
Background The cationic lipid Genzyme lipid (GL) 67 is the current "gold-standard" for in vivo lung gene transfer. Here, we assessed, if GL67 mediated uptake of siRNAs and asODNs into airway epithelium in vivo. Methods Anti-lacZ and ENaC (epithelial sodium channel) siRNA and asODN were complexed to GL67 and administered to the mouse airway epithelium in vivo Transfection efficiency and efficacy were assessed using real-time RT-PCR as well as through protein expression and functional studies. In parallel in vitro experiments were carried out to select the most efficient oligonucleotides. Results In vitro, GL67 efficiently complexed asODNs and siRNAs, and both were stable in exhaled breath condensate. Importantly, during in vitro selection of functional siRNA and asODN we noted that asODNs accumulated rapidly in the nuclei of transfected cells, whereas siRNAs remained in the cytoplasm, a pattern consistent with their presumed site of action. Following in vivo lung transfection siRNAs were only visible in alveolar macrophages, whereas asODN also transfected alveolar epithelial cells, but no significant uptake into conducting airway epithelial cells was seen. SiRNAs and asODNs targeted to β-galactosidase reduced βgal mRNA levels in the airway epithelium of K18-lacZ mice by 30% and 60%, respectively. However, this was insufficient to reduce protein expression. In an attempt to increase transfection efficiency of the airway epithelium, we increased contact time of siRNA and asODN using the in vivo mouse nose model. Although highly variable and inefficient, transfection of airway epithelium with asODN, but not siRNA, was now seen. As asODNs more effectively transfected nasal airway epithelial cells, we assessed the effect of asODN against ENaC, a potential therapeutic target in cystic fibrosis; no decrease in ENaC mRNA levels or function was detected. Conclusion This study suggests that although siRNAs and asODNs can be developed to inhibit gene expression in culture systems and certain organs in vivo, barriers to nucleic acid transfer in airway epithelial cells seen with large DNA molecules may also affect the efficiency of in vivo uptake of small nucleic acid molecules.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Careers

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,603,474 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

asodn, sirna, transfection, cells, lung, airway, gene, enac, pubmed, article, protein, mrna, hours, vivo, lacz, google, scholar, epithelial, cas, expression, sirnas, complexed, nucleic, epithelium, nasal, rna, figure, acid, βgal, asodns, shown, min, mouse, distribution, control, data, transfer, cystic, fibrosis, stability, fitclabelled, group, efficiency, transfected, size, complexes, mice, murine, full, vitro,

Topics {✒️}

double-blind placebo-controlled trial low-pass signal-averaging filter open access article nih-3t3-lacz cells yu-hua chow small double-stranded rnas article download pdf β-galactosidase protein expression β-gal reporter kit real-time quantitative pcr small interfering rna real-time rt-pcr fitc versus biotin-streptavidin global anti-viral responses cell culture-based systems double-stranded dna oligonucleotides double-lumen polyethylene catheter asodn-mediated gene silencing lipid-complexed fitc-labelled sirna rnai-mediated gene silencing semi-confluent m1 cells epithelium-specific expression cassette fitc-labelled nucleic acids quantitative rt-pcr carried fitc-labelled sirna/gl67 complexes exhaled breath condensate k18-lacz transgenic mice express β-galactosidase screening anti-enac sirna cystic fibrosis mice directly targeting mrna antisense oligonucleotide-rna duplexes uk home office clinical respiratory medicine develop computer-assisted design independent sample t-test lung biology research gene expression mediated mark edbrooke aerosolized lipid-dna administration quantitative rt-pcr nucleic acid size pulmonary inflammatory diseases β-gal protein high auto-fluorescence epithelial cells mediated β-gal mrna small nucleic acid privacy choices/manage cookies airway gene transfer

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo
         description:The cationic lipid Genzyme lipid (GL) 67 is the current "gold-standard" for in vivo lung gene transfer. Here, we assessed, if GL67 mediated uptake of siRNAs and asODNs into airway epithelium in vivo. Anti-lacZ and ENaC (epithelial sodium channel) siRNA and asODN were complexed to GL67 and administered to the mouse airway epithelium in vivo Transfection efficiency and efficacy were assessed using real-time RT-PCR as well as through protein expression and functional studies. In parallel in vitro experiments were carried out to select the most efficient oligonucleotides. In vitro, GL67 efficiently complexed asODNs and siRNAs, and both were stable in exhaled breath condensate. Importantly, during in vitro selection of functional siRNA and asODN we noted that asODNs accumulated rapidly in the nuclei of transfected cells, whereas siRNAs remained in the cytoplasm, a pattern consistent with their presumed site of action. Following in vivo lung transfection siRNAs were only visible in alveolar macrophages, whereas asODN also transfected alveolar epithelial cells, but no significant uptake into conducting airway epithelial cells was seen. SiRNAs and asODNs targeted to β-galactosidase reduced βgal mRNA levels in the airway epithelium of K18-lacZ mice by 30% and 60%, respectively. However, this was insufficient to reduce protein expression. In an attempt to increase transfection efficiency of the airway epithelium, we increased contact time of siRNA and asODN using the in vivo mouse nose model. Although highly variable and inefficient, transfection of airway epithelium with asODN, but not siRNA, was now seen. As asODNs more effectively transfected nasal airway epithelial cells, we assessed the effect of asODN against ENaC, a potential therapeutic target in cystic fibrosis; no decrease in ENaC mRNA levels or function was detected. This study suggests that although siRNAs and asODNs can be developed to inhibit gene expression in culture systems and certain organs in vivo, barriers to nucleic acid transfer in airway epithelial cells seen with large DNA molecules may also affect the efficiency of in vivo uptake of small nucleic acid molecules.
         datePublished:2006-02-15T00:00:00Z
         dateModified:2006-02-15T00:00:00Z
         pageStart:1
         pageEnd:15
         license:https://creativecommons.org/licenses/by/2.0
         sameAs:https://doi.org/10.1186/1465-9921-7-26
         keywords:
            Cystic Fibrosis Transmembrane Conductance Regulator
            Cystic Fibrosis Patient
            Airway Epithelial Cell
            Airway Epithelium
            Exhale Breath Condensate
            Pneumology/Respiratory System
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig6_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig7_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig8_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig9_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig10_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig11_HTML.jpg
         isPartOf:
            name:Respiratory Research
            issn:
               1465-993X
            volumeNumber:7
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Uta Griesenbach
               affiliation:
                     name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
                     address:
                        name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
                        type:PostalAddress
                     type:Organization
                     name:UK Cystic Fibrosis Gene Therapy Consortium
                     address:
                        name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Chris Kitson
               affiliation:
                     name:GlaxoSmithKline
                     address:
                        name:GlaxoSmithKline, Middlesex, United Kingdom
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Escudero Sara Garcia
               affiliation:
                     name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
                     address:
                        name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
                        type:PostalAddress
                     type:Organization
                     name:UK Cystic Fibrosis Gene Therapy Consortium
                     address:
                        name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Raymond Farley
               affiliation:
                     name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
                     address:
                        name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
                        type:PostalAddress
                     type:Organization
                     name:UK Cystic Fibrosis Gene Therapy Consortium
                     address:
                        name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Charanjit Singh
               affiliation:
                     name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
                     address:
                        name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
                        type:PostalAddress
                     type:Organization
                     name:UK Cystic Fibrosis Gene Therapy Consortium
                     address:
                        name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Luci Somerton
               affiliation:
                     name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
                     address:
                        name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
                        type:PostalAddress
                     type:Organization
                     name:UK Cystic Fibrosis Gene Therapy Consortium
                     address:
                        name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hazel Painter
               affiliation:
                     name:John Radcliffe Hospital, University of Oxford
                     address:
                        name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rbecca L Smith
               affiliation:
                     name:John Radcliffe Hospital, University of Oxford
                     address:
                        name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Deborah R Gill
               affiliation:
                     name:John Radcliffe Hospital, University of Oxford
                     address:
                        name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stephen C Hyde
               affiliation:
                     name:John Radcliffe Hospital, University of Oxford
                     address:
                        name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yu-Hua Chow
               affiliation:
                     name:University of Toronto
                     address:
                        name:Programme in Lung Biology Research, Hospital for Sick Children and Department of Laboratory Medicine and Pathobiology, University of Toronto, Mississauga
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jim Hu
               affiliation:
                     name:University of Toronto
                     address:
                        name:Programme in Lung Biology Research, Hospital for Sick Children and Department of Laboratory Medicine and Pathobiology, University of Toronto, Mississauga
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mike Gray
               affiliation:
                     name:University Medical School
                     address:
                        name:Institute for Cell and Molecular Biosciences, University Medical School, Newcastle, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mark Edbrooke
               affiliation:
                     name:GlaxoSmithKline
                     address:
                        name:GlaxoSmithKline, Middlesex, United Kingdom
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Varrie Ogilvie
               affiliation:
                     name:University of Edinburgh
                     address:
                        name:Medical Genetics Section, University of Edinburgh, Edinburgh, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gordon MacGregor
               affiliation:
                     name:University of Edinburgh
                     address:
                        name:Medical Genetics Section, University of Edinburgh, Edinburgh, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ronald K Scheule
               affiliation:
                     name:Genzyme Corporation
                     address:
                        name:Genzyme Corporation, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Seng H Cheng
               affiliation:
                     name:Genzyme Corporation
                     address:
                        name:Genzyme Corporation, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Natasha J Caplen
               affiliation:
                     name:National Human Genome Research Institute, National Institutes of Health
                     address:
                        name:Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda
                        type:PostalAddress
                     type:Organization
                     name:National Cancer Institute, National Institutes of Health
                     address:
                        name:Gene Silencing Section, National Cancer Institute, National Institutes of Health, Bethesda
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eric WFW Alton
               affiliation:
                     name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
                     address:
                        name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
                        type:PostalAddress
                     type:Organization
                     name:UK Cystic Fibrosis Gene Therapy Consortium
                     address:
                        name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo
      description:The cationic lipid Genzyme lipid (GL) 67 is the current "gold-standard" for in vivo lung gene transfer. Here, we assessed, if GL67 mediated uptake of siRNAs and asODNs into airway epithelium in vivo. Anti-lacZ and ENaC (epithelial sodium channel) siRNA and asODN were complexed to GL67 and administered to the mouse airway epithelium in vivo Transfection efficiency and efficacy were assessed using real-time RT-PCR as well as through protein expression and functional studies. In parallel in vitro experiments were carried out to select the most efficient oligonucleotides. In vitro, GL67 efficiently complexed asODNs and siRNAs, and both were stable in exhaled breath condensate. Importantly, during in vitro selection of functional siRNA and asODN we noted that asODNs accumulated rapidly in the nuclei of transfected cells, whereas siRNAs remained in the cytoplasm, a pattern consistent with their presumed site of action. Following in vivo lung transfection siRNAs were only visible in alveolar macrophages, whereas asODN also transfected alveolar epithelial cells, but no significant uptake into conducting airway epithelial cells was seen. SiRNAs and asODNs targeted to β-galactosidase reduced βgal mRNA levels in the airway epithelium of K18-lacZ mice by 30% and 60%, respectively. However, this was insufficient to reduce protein expression. In an attempt to increase transfection efficiency of the airway epithelium, we increased contact time of siRNA and asODN using the in vivo mouse nose model. Although highly variable and inefficient, transfection of airway epithelium with asODN, but not siRNA, was now seen. As asODNs more effectively transfected nasal airway epithelial cells, we assessed the effect of asODN against ENaC, a potential therapeutic target in cystic fibrosis; no decrease in ENaC mRNA levels or function was detected. This study suggests that although siRNAs and asODNs can be developed to inhibit gene expression in culture systems and certain organs in vivo, barriers to nucleic acid transfer in airway epithelial cells seen with large DNA molecules may also affect the efficiency of in vivo uptake of small nucleic acid molecules.
      datePublished:2006-02-15T00:00:00Z
      dateModified:2006-02-15T00:00:00Z
      pageStart:1
      pageEnd:15
      license:https://creativecommons.org/licenses/by/2.0
      sameAs:https://doi.org/10.1186/1465-9921-7-26
      keywords:
         Cystic Fibrosis Transmembrane Conductance Regulator
         Cystic Fibrosis Patient
         Airway Epithelial Cell
         Airway Epithelium
         Exhale Breath Condensate
         Pneumology/Respiratory System
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig6_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig7_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig8_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig9_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig10_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1465-9921-7-26/MediaObjects/12931_2005_417_Fig11_HTML.jpg
      isPartOf:
         name:Respiratory Research
         issn:
            1465-993X
         volumeNumber:7
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Uta Griesenbach
            affiliation:
                  name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
                  address:
                     name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
                     type:PostalAddress
                  type:Organization
                  name:UK Cystic Fibrosis Gene Therapy Consortium
                  address:
                     name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Chris Kitson
            affiliation:
                  name:GlaxoSmithKline
                  address:
                     name:GlaxoSmithKline, Middlesex, United Kingdom
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Escudero Sara Garcia
            affiliation:
                  name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
                  address:
                     name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
                     type:PostalAddress
                  type:Organization
                  name:UK Cystic Fibrosis Gene Therapy Consortium
                  address:
                     name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Raymond Farley
            affiliation:
                  name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
                  address:
                     name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
                     type:PostalAddress
                  type:Organization
                  name:UK Cystic Fibrosis Gene Therapy Consortium
                  address:
                     name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Charanjit Singh
            affiliation:
                  name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
                  address:
                     name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
                     type:PostalAddress
                  type:Organization
                  name:UK Cystic Fibrosis Gene Therapy Consortium
                  address:
                     name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Luci Somerton
            affiliation:
                  name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
                  address:
                     name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
                     type:PostalAddress
                  type:Organization
                  name:UK Cystic Fibrosis Gene Therapy Consortium
                  address:
                     name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hazel Painter
            affiliation:
                  name:John Radcliffe Hospital, University of Oxford
                  address:
                     name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rbecca L Smith
            affiliation:
                  name:John Radcliffe Hospital, University of Oxford
                  address:
                     name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Deborah R Gill
            affiliation:
                  name:John Radcliffe Hospital, University of Oxford
                  address:
                     name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stephen C Hyde
            affiliation:
                  name:John Radcliffe Hospital, University of Oxford
                  address:
                     name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yu-Hua Chow
            affiliation:
                  name:University of Toronto
                  address:
                     name:Programme in Lung Biology Research, Hospital for Sick Children and Department of Laboratory Medicine and Pathobiology, University of Toronto, Mississauga
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jim Hu
            affiliation:
                  name:University of Toronto
                  address:
                     name:Programme in Lung Biology Research, Hospital for Sick Children and Department of Laboratory Medicine and Pathobiology, University of Toronto, Mississauga
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mike Gray
            affiliation:
                  name:University Medical School
                  address:
                     name:Institute for Cell and Molecular Biosciences, University Medical School, Newcastle, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mark Edbrooke
            affiliation:
                  name:GlaxoSmithKline
                  address:
                     name:GlaxoSmithKline, Middlesex, United Kingdom
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Varrie Ogilvie
            affiliation:
                  name:University of Edinburgh
                  address:
                     name:Medical Genetics Section, University of Edinburgh, Edinburgh, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gordon MacGregor
            affiliation:
                  name:University of Edinburgh
                  address:
                     name:Medical Genetics Section, University of Edinburgh, Edinburgh, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ronald K Scheule
            affiliation:
                  name:Genzyme Corporation
                  address:
                     name:Genzyme Corporation, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Seng H Cheng
            affiliation:
                  name:Genzyme Corporation
                  address:
                     name:Genzyme Corporation, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Natasha J Caplen
            affiliation:
                  name:National Human Genome Research Institute, National Institutes of Health
                  address:
                     name:Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda
                     type:PostalAddress
                  type:Organization
                  name:National Cancer Institute, National Institutes of Health
                  address:
                     name:Gene Silencing Section, National Cancer Institute, National Institutes of Health, Bethesda
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eric WFW Alton
            affiliation:
                  name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
                  address:
                     name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
                     type:PostalAddress
                  type:Organization
                  name:UK Cystic Fibrosis Gene Therapy Consortium
                  address:
                     name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Respiratory Research
      issn:
         1465-993X
      volumeNumber:7
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
      address:
         name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
         type:PostalAddress
      name:UK Cystic Fibrosis Gene Therapy Consortium
      address:
         name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
         type:PostalAddress
      name:GlaxoSmithKline
      address:
         name:GlaxoSmithKline, Middlesex, United Kingdom
         type:PostalAddress
      name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
      address:
         name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
         type:PostalAddress
      name:UK Cystic Fibrosis Gene Therapy Consortium
      address:
         name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
         type:PostalAddress
      name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
      address:
         name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
         type:PostalAddress
      name:UK Cystic Fibrosis Gene Therapy Consortium
      address:
         name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
         type:PostalAddress
      name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
      address:
         name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
         type:PostalAddress
      name:UK Cystic Fibrosis Gene Therapy Consortium
      address:
         name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
         type:PostalAddress
      name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
      address:
         name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
         type:PostalAddress
      name:UK Cystic Fibrosis Gene Therapy Consortium
      address:
         name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
         type:PostalAddress
      name:John Radcliffe Hospital, University of Oxford
      address:
         name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
         type:PostalAddress
      name:John Radcliffe Hospital, University of Oxford
      address:
         name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
         type:PostalAddress
      name:John Radcliffe Hospital, University of Oxford
      address:
         name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
         type:PostalAddress
      name:John Radcliffe Hospital, University of Oxford
      address:
         name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
         type:PostalAddress
      name:University of Toronto
      address:
         name:Programme in Lung Biology Research, Hospital for Sick Children and Department of Laboratory Medicine and Pathobiology, University of Toronto, Mississauga
         type:PostalAddress
      name:University of Toronto
      address:
         name:Programme in Lung Biology Research, Hospital for Sick Children and Department of Laboratory Medicine and Pathobiology, University of Toronto, Mississauga
         type:PostalAddress
      name:University Medical School
      address:
         name:Institute for Cell and Molecular Biosciences, University Medical School, Newcastle, UK
         type:PostalAddress
      name:GlaxoSmithKline
      address:
         name:GlaxoSmithKline, Middlesex, United Kingdom
         type:PostalAddress
      name:University of Edinburgh
      address:
         name:Medical Genetics Section, University of Edinburgh, Edinburgh, UK
         type:PostalAddress
      name:University of Edinburgh
      address:
         name:Medical Genetics Section, University of Edinburgh, Edinburgh, UK
         type:PostalAddress
      name:Genzyme Corporation
      address:
         name:Genzyme Corporation, USA
         type:PostalAddress
      name:Genzyme Corporation
      address:
         name:Genzyme Corporation, USA
         type:PostalAddress
      name:National Human Genome Research Institute, National Institutes of Health
      address:
         name:Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda
         type:PostalAddress
      name:National Cancer Institute, National Institutes of Health
      address:
         name:Gene Silencing Section, National Cancer Institute, National Institutes of Health, Bethesda
         type:PostalAddress
      name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
      address:
         name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
         type:PostalAddress
      name:UK Cystic Fibrosis Gene Therapy Consortium
      address:
         name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Uta Griesenbach
      affiliation:
            name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
            address:
               name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
               type:PostalAddress
            type:Organization
            name:UK Cystic Fibrosis Gene Therapy Consortium
            address:
               name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Chris Kitson
      affiliation:
            name:GlaxoSmithKline
            address:
               name:GlaxoSmithKline, Middlesex, United Kingdom
               type:PostalAddress
            type:Organization
      name:Escudero Sara Garcia
      affiliation:
            name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
            address:
               name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
               type:PostalAddress
            type:Organization
            name:UK Cystic Fibrosis Gene Therapy Consortium
            address:
               name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
               type:PostalAddress
            type:Organization
      name:Raymond Farley
      affiliation:
            name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
            address:
               name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
               type:PostalAddress
            type:Organization
            name:UK Cystic Fibrosis Gene Therapy Consortium
            address:
               name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
               type:PostalAddress
            type:Organization
      name:Charanjit Singh
      affiliation:
            name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
            address:
               name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
               type:PostalAddress
            type:Organization
            name:UK Cystic Fibrosis Gene Therapy Consortium
            address:
               name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
               type:PostalAddress
            type:Organization
      name:Luci Somerton
      affiliation:
            name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
            address:
               name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
               type:PostalAddress
            type:Organization
            name:UK Cystic Fibrosis Gene Therapy Consortium
            address:
               name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
               type:PostalAddress
            type:Organization
      name:Hazel Painter
      affiliation:
            name:John Radcliffe Hospital, University of Oxford
            address:
               name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
               type:PostalAddress
            type:Organization
      name:Rbecca L Smith
      affiliation:
            name:John Radcliffe Hospital, University of Oxford
            address:
               name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
               type:PostalAddress
            type:Organization
      name:Deborah R Gill
      affiliation:
            name:John Radcliffe Hospital, University of Oxford
            address:
               name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
               type:PostalAddress
            type:Organization
      name:Stephen C Hyde
      affiliation:
            name:John Radcliffe Hospital, University of Oxford
            address:
               name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
               type:PostalAddress
            type:Organization
      name:Yu-Hua Chow
      affiliation:
            name:University of Toronto
            address:
               name:Programme in Lung Biology Research, Hospital for Sick Children and Department of Laboratory Medicine and Pathobiology, University of Toronto, Mississauga
               type:PostalAddress
            type:Organization
      name:Jim Hu
      affiliation:
            name:University of Toronto
            address:
               name:Programme in Lung Biology Research, Hospital for Sick Children and Department of Laboratory Medicine and Pathobiology, University of Toronto, Mississauga
               type:PostalAddress
            type:Organization
      name:Mike Gray
      affiliation:
            name:University Medical School
            address:
               name:Institute for Cell and Molecular Biosciences, University Medical School, Newcastle, UK
               type:PostalAddress
            type:Organization
      name:Mark Edbrooke
      affiliation:
            name:GlaxoSmithKline
            address:
               name:GlaxoSmithKline, Middlesex, United Kingdom
               type:PostalAddress
            type:Organization
      name:Varrie Ogilvie
      affiliation:
            name:University of Edinburgh
            address:
               name:Medical Genetics Section, University of Edinburgh, Edinburgh, UK
               type:PostalAddress
            type:Organization
      name:Gordon MacGregor
      affiliation:
            name:University of Edinburgh
            address:
               name:Medical Genetics Section, University of Edinburgh, Edinburgh, UK
               type:PostalAddress
            type:Organization
      name:Ronald K Scheule
      affiliation:
            name:Genzyme Corporation
            address:
               name:Genzyme Corporation, USA
               type:PostalAddress
            type:Organization
      name:Seng H Cheng
      affiliation:
            name:Genzyme Corporation
            address:
               name:Genzyme Corporation, USA
               type:PostalAddress
            type:Organization
      name:Natasha J Caplen
      affiliation:
            name:National Human Genome Research Institute, National Institutes of Health
            address:
               name:Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda
               type:PostalAddress
            type:Organization
            name:National Cancer Institute, National Institutes of Health
            address:
               name:Gene Silencing Section, National Cancer Institute, National Institutes of Health, Bethesda
               type:PostalAddress
            type:Organization
      name:Eric WFW Alton
      affiliation:
            name:Faculty of Medicine at the National Heart and Lung Institute, Imperial College
            address:
               name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
               type:PostalAddress
            type:Organization
            name:UK Cystic Fibrosis Gene Therapy Consortium
            address:
               name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
      name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
      name:GlaxoSmithKline, Middlesex, United Kingdom
      name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
      name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
      name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
      name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
      name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
      name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
      name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
      name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK
      name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
      name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
      name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
      name:Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
      name:Programme in Lung Biology Research, Hospital for Sick Children and Department of Laboratory Medicine and Pathobiology, University of Toronto, Mississauga
      name:Programme in Lung Biology Research, Hospital for Sick Children and Department of Laboratory Medicine and Pathobiology, University of Toronto, Mississauga
      name:Institute for Cell and Molecular Biosciences, University Medical School, Newcastle, UK
      name:GlaxoSmithKline, Middlesex, United Kingdom
      name:Medical Genetics Section, University of Edinburgh, Edinburgh, UK
      name:Medical Genetics Section, University of Edinburgh, Edinburgh, UK
      name:Genzyme Corporation, USA
      name:Genzyme Corporation, USA
      name:Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda
      name:Gene Silencing Section, National Cancer Institute, National Institutes of Health, Bethesda
      name:Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK
      name:UK Cystic Fibrosis Gene Therapy Consortium, London, UK

External Links {🔗}(162)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.55s.